Narrow search
Showing 1 - 10 of 436
Cover Image
Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries
Hens, Manuel; Villaverde-Hueso, Ana; Alonso, Veronica; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 433-437
Persistent link: https://www.econbiz.de/10010383394
Cover Image
Stratified medicine in schizophrenia : how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
Jin, Huajie; McCrone, Paul; MacCabe, James H. - In: The European journal of health economics : HEPAC ; … 20 (2019) 9, pp. 1425-1435
Persistent link: https://www.econbiz.de/10012221385
Cover Image
Using health technology assessment to assess the value of new medicines : results of a systematic review and expert consultation across eight European countries
Angelis, Aris; Lange, Ansgar; Kanavos, Panos - In: The European journal of health economics : HEPAC ; … 19 (2018) 1, pp. 123-152
Persistent link: https://www.econbiz.de/10011946167
Cover Image
The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States : relationship to cost‑effectiveness analysis and...
Ghabri, Salah; Mauskopf, Josephine - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 173-175
Persistent link: https://www.econbiz.de/10011946183
Cover Image
Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom
Wilson, Michele R.; Bergman, Annika; Chevrou-Severac, Helene - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 229-240
Persistent link: https://www.econbiz.de/10011946252
Cover Image
Priorities in the Polish health care system
Nieszporska, Sylwia - In: The European journal of health economics : HEPAC ; … 18 (2017) 1, pp. 1-5
Persistent link: https://www.econbiz.de/10011867802
Cover Image
Procedures and methods of benefit assessments for medicines in Germany
Bekkering, Geertruida E.; Kleijnen, Jos - In: The European journal of health economics : HEPAC ; … 9 (2008), pp. 5-29
Persistent link: https://www.econbiz.de/10003792495
Cover Image
Procedures and methods of benefit assessments for medicines in Germany : give the child a name
Schünemann, Holger J.; Kunz, Regina; Falck-Ytter, Yngve; … - In: The European journal of health economics : HEPAC ; … 10 (2009) 2, pp. 237-238
Persistent link: https://www.econbiz.de/10009522672
Cover Image
Response to the expertise : procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen
Koch, Klaus; Lange, Stefan - In: The European journal of health economics : HEPAC ; … 10 (2009) 2, pp. 233-236
Persistent link: https://www.econbiz.de/10009522673
Cover Image
Cost of managing anemia in end-stage renal disease : the experience of five French dialysis centers
Rottembourg, Jacques; Tilleul, Patrick; Deray, Gilbert; … - In: The European journal of health economics : HEPAC ; … 16 (2015) 4, pp. 357-364
Persistent link: https://www.econbiz.de/10011299729